Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06680674

Multinational Point Prevalence Study on the Management of Diabesity in Hospitals

Diabetes related to obesity ("diabesity") is becoming increasingly prevalent. Hospitalizations among people with diabetes are frequent and glycaemic control is often suboptimal during these stays.

However, the pharmacological treatment of diabesity has made significant progress in recent years.

The objective of this study is to assess the management of diabesity in the international hospital setting. Aims include:

1. to determine the prevalence of causes and duration of hospitalization 2. to investigate the treatments used 3. to determine individual metabolic control achived This is a cross-sectional multi-centre study in which researchers will conduct a one-day point prevalence assessment in internal medicine wards.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Diabetes Mellitus Body Weight Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutrition Disorders Nutritional and Metabolic Diseases Obesity Overnutrition Overweight Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Medical University of Vienna, Vienna, Austria

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Hospitalized at the time of the survey for any cause
  • Diabetes diagnosis (Known / documented in medical history or newly diagnosed using ADA diagnostic criteria)
  • Age ≥ 18 years
  • Written informed consent

Exclusion criteria

  • Patients in wards and units other than internal medicine wards (such as outpatient areas, emergency departments, skilled nursing and intensive care units, etc.)
  • Paediatric patients (Age < 18 years)
  • Patients without a diabetes diagnosis

Treatment and study plan

Routine care for people with diabetes, with or without obesity, in the hospital setting

Other

Routine care for people with diabetes, with or without obesity, in the hospital setting, including routine pharmacological treatment for diabetes and obesity.

Primary outcomes

  1. Number of point-of-care glucose values

    Time frame: 3 days

    Mean number of point-of-care glucose measurements during hospitalization

Secondary outcomes

  1. Severe hypoglycaemia

    Time frame: From day of admission to the day of data collection, i.e., November 14, 2024

    Severe hypoglycaemia during admission (glucose <40mg/dL)

Other outcomes

  1. Diabetes treatment during hospitalization

    Time frame: From day of admission to the day of data collection, i.e., November 14, 2024

    Diabetes treatment used during the time of hospitalization

  2. Insulin regimen during hospitalization

    Time frame: From day of admission to the day of data collection, i.e., November 14, 2024

    Insulin regimen used during the time of hospitalization (e.g., correction, basal, prandial bolus)

Sponsors and collaborators

Lead sponsor

Medical University of Vienna

Other

Collaborators

  • Aristotle University Of Thessaloniki
  • Centre Hospitalier Universitaire Sétif, Service Médecine Interne (Algeria)
  • Charles University, Czech Republic
  • Complejo Hospitalario de Especialidades Juan Ramón Jimenez
  • Hospital Marina Baixa
  • Hospital Regional de Malaga
  • Hospital de Cascais Dr. José de Almeida (Portugal)
  • Kanuni Sultan Suleyman Training and Research Hospital
  • Medical University Innsbruck
  • Rabin Medical Center
  • Riga East Clinical University Hospital
  • Rostov State Medical University
  • San Raffaele University Hospital, Italy
  • University Hospital Bratislava
  • University Hospital, Aachen

Registry information

Official study title

Multinational Cross-sectional Review of Diabetes and Obesity Management in Hospitals Across Europe: The DIABESITY Survey

Acronym: DiabesityDay

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Nov 8, 2024
Registry last updated
May 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.